Mineralys Therapeutics (MLYS) News Today $38.78 0.00 (0.00%) As of 10:06 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MLYS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Given Consensus Recommendation of "Moderate Buy" by BrokeragesSeptember 22 at 4:40 AM | marketbeat.comSwedbank AB Buys 56,100 Shares of Mineralys Therapeutics, Inc. $MLYSSeptember 22 at 3:39 AM | marketbeat.comThese 2 Healthcare Stocks Are Up Over 100% in a Month. Can They Keep Climbing?September 21 at 6:43 PM | fool.comMineralys Therapeutics (NASDAQ:MLYS) Hits New 1-Year High - Should You Buy?September 19, 2025 | marketbeat.comMineralys Therapeutics (NASDAQ:MLYS) Insider Sells $409,212.00 in StockSeptember 17, 2025 | marketbeat.comDid New Phase 3 Results and FDA Milestones Just Shift Mineralys Therapeutics' (MLYS) Investment Narrative?September 17, 2025 | finance.yahoo.comSwedbank AB Takes $5.20 Million Position in Mineralys Therapeutics, Inc. $MLYSSeptember 17, 2025 | marketbeat.comGoldman Sachs Group Inc. Purchases 186,480 Shares of Mineralys Therapeutics, Inc. $MLYSSeptember 17, 2025 | marketbeat.comMineralys Therapeutics (NASDAQ:MLYS) Trading Down 5% - Should You Sell?September 16, 2025 | marketbeat.comMineralys Therapeutics falls -4.9%September 15, 2025 | msn.comMineralys Therapeutics (NASDAQ:MLYS) Sees Unusually-High Trading Volume Following Analyst UpgradeSeptember 13, 2025 | marketbeat.comWells Fargo & Company Increases Mineralys Therapeutics (NASDAQ:MLYS) Price Target to $50.00September 13, 2025 | marketbeat.comMineralys Therapeutics (NASDAQ:MLYS) Sees Strong Trading Volume on Analyst UpgradeSeptember 13, 2025 | americanbankingnews.comMineralys Therapeutics (NASDAQ:MLYS) Price Target Raised to $50.00 at Wells Fargo & CompanySeptember 12, 2025 | americanbankingnews.comMineralys Therapeutics price target raised to $50 from $26 at Wells FargoSeptember 11, 2025 | msn.comThe Goldman Sachs Group Increases Mineralys Therapeutics (NASDAQ:MLYS) Price Target to $52.00September 11, 2025 | marketbeat.comJefferies Reaffirms Their Hold Rating on Mineralys Therapeutics, Inc. (MLYS)September 10, 2025 | theglobeandmail.comMineralys Therapeutics (NASDAQ:MLYS) Director Srinivas Akkaraju Acquires 588,235 Shares of StockSeptember 10, 2025 | marketbeat.comRa Capital Management, L.P. Acquires 1,176,470 Shares of Mineralys Therapeutics (NASDAQ:MLYS) StockSeptember 10, 2025 | marketbeat.comMineralys Therapeutics (NASDAQ:MLYS) Reaches New 52-Week High - Here's WhySeptember 10, 2025 | marketbeat.comHC Wainwright Reiterates Buy Rating for Mineralys Therapeutics (NASDAQ:MLYS)September 10, 2025 | marketbeat.comPolar Asset Management Partners Inc. Sells 78,970 Shares of Mineralys Therapeutics, Inc. $MLYSSeptember 9, 2025 | marketbeat.comMineralys Therapeutics (NASDAQ:MLYS) Director Buys $14,999,992.50 in StockSeptember 9, 2025 | insidertrades.comParkman Healthcare Partners LLC Buys Shares of 293,928 Mineralys Therapeutics, Inc. $MLYSSeptember 8, 2025 | marketbeat.comCinctive Capital Management LP Invests $226,000 in Mineralys Therapeutics, Inc. $MLYSSeptember 8, 2025 | marketbeat.comBuy Rating Affirmed for Mineralys Therapeutics Due to Promising Hypertension Drug Data and Market PositionSeptember 8, 2025 | tipranks.comThese 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street AnalystsSeptember 7, 2025 | fool.comTrexquant Investment LP Buys New Stake in Mineralys Therapeutics, Inc. $MLYSSeptember 7, 2025 | marketbeat.comMineralys Therapeutics (NASDAQ:MLYS) Trading Up 5.3% on Analyst UpgradeSeptember 6, 2025 | marketbeat.com279,500 Shares in Mineralys Therapeutics, Inc. $MLYS Purchased by Canada Pension Plan Investment BoardSeptember 6, 2025 | marketbeat.comMineralys Therapeutics Presents Subgroup Analyses of Phase 3 Launch-HTN Trial Demonstrating Efficacy and Safety of Lorundrostat in Hypertension Participants with High Unmet ...September 5, 2025 | finance.yahoo.comMineralys Therapeutics (NASDAQ:MLYS) Shares Gap Down - Time to Sell?September 5, 2025 | marketbeat.comMineralys Therapeutics Presents Subgroup Analyses of Phase 3 Launch-HTN Trial Demonstrating Efficacy and Safety of Lorundrostat in Hypertension Participants with High Unmet Medical NeedSeptember 5, 2025 | globenewswire.comMineralys Therapeutics (NASDAQ:MLYS) Stock Price Expected to Rise, Jefferies Financial Group Analyst SaysSeptember 5, 2025 | marketbeat.comMineralys Therapeutics Announces Closing of Upsized $287.5 Million Underwritten Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase ...September 4, 2025 | markets.businessinsider.comMineralys Therapeutics Announces Closing of Upsized $287.5 Million Underwritten Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional SharesSeptember 4, 2025 | globenewswire.comMineralys Therapeutics (NASDAQ:MLYS) Hits New 1-Year High - What's Next?September 4, 2025 | marketbeat.comMineralys Therapeutics, Inc. $MLYS Shares Sold by ADAR1 Capital Management LLCSeptember 4, 2025 | marketbeat.comMineralys Therapeutics, Inc. $MLYS Shares Bought by RA Capital Management L.P.September 4, 2025 | marketbeat.comMineralys: Soaring As Rival's Hypertension Data Falls Short - Buy The Next DipSeptember 4, 2025 | seekingalpha.comStocks Showing Market Leadership: Mineralys Therapeutics Earns 98 RS RatingSeptember 3, 2025 | msn.comMineralys (MLYS) Steals Spotlight From AstraZeneca, Reaches Fresh PeakSeptember 3, 2025 | msn.comMineralys Therapeutics announces $175M common stock offeringSeptember 3, 2025 | msn.comBruker, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market SessionSeptember 3, 2025 | benzinga.comMineralys Therapeutics, Inc. $MLYS Shares Acquired by Nantahala Capital Management LLCSeptember 3, 2025 | marketbeat.comNuveen LLC Invests $1.08 Million in Mineralys Therapeutics, Inc. $MLYSSeptember 3, 2025 | marketbeat.comMineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common StockSeptember 2, 2025 | globenewswire.comMineralys Therapeutics Halts Common Stock OfferingSeptember 2, 2025 | tipranks.comMineralys Therapeutics Announces Proposed Public Offering of Common StockSeptember 2, 2025 | globenewswire.comMineralys surges after late-stage trial data AstraZeneca’s blood pressure drugSeptember 2, 2025 | msn.com Get Mineralys Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MLYS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MLYS Media Mentions By Week MLYS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MLYS News Sentiment▼0.630.73▲Average Medical News Sentiment MLYS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MLYS Articles This Week▼106▲MLYS Articles Average Week Get the Latest News and Ratings for MLYS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Mineralys Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies BBIO News Today ROIV News Today ELAN News Today MRNA News Today VRNA News Today RVMD News Today GRFS News Today RYTM News Today ABVX News Today CYTK News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MLYS) was last updated on 9/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mineralys Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mineralys Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
